Moderna
MRNA
$0.00 (0.00%)
1D
1W
3M
1Y
5Y
ALL
Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger ribonucleic acid (mRNA), to improve the lives of patients. The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. It is developing vaccines and therapeutics for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases, independently and with its strategic collaborators. The Company develops technologies that enable the development of mRNA medicines for diverse applications. It has created modalities, including prophylactic vaccines, systemic secreted and cell surface therapeutics, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, and systemic intracellular therapeutics.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
The Motley Fool • 2 days ago • MRNA
Should You Buy This Stock After a Regulatory Setback?Barrons • 4 days ago • MRNA
Cancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know.The Motley Fool • 4 days ago • MRNA
Why Vaccine Stocks Rallied This WeekZacks Investment Research • 5 days ago • MRNA
Vaccine Stocks Rise on Growing Threat of Bird Flu InfectionsInvestorPlace • 5 days ago • MRNA
The Moderna News That Has MRNA Stock Price Surging: 3 Key CatalystsCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.